Peiyan Hua

机构：Second Affiliated Hospital of Jilin University · ORCID：0000-0001-9153-9287

发表论文 45 篇 · 总被引 790 次 · h-index 17

代表论文

The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy (2021 · Life Sciences · 被引 69)
LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p (2021 · Molecular Biotechnology · 被引 29)
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis (2022 · Frontiers in Oncology · 被引 25)
RETRACTED ARTICLE: Circular RNA circDLGAP4 is involved in lung cancer development through modulating microRNA-143/CDK1 axis (2020 · Cell Cycle · 被引 20)
Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade (2024 · Materials Today Bio · 被引 17)
Exosomes: efficient macrophage-related immunomodulators in chronic lung diseases (2024 · Frontiers in Cell and Developmental Biology · 被引 17)